{"title":"Overview of Methods and Strategies for Conducting Virtual Small Molecule Screening","authors":"Xavier Fradera, Kerim Babaoglu","doi":"10.1002/cpch.27","DOIUrl":null,"url":null,"abstract":"<p>Virtual screening (VS) in the context of drug discovery is the use of computational methods to discover novel ligands with a desired biological activity from within a larger collection of molecules. These techniques have been in use for many years, there is a wide range of methodologies available, and many successful applications have been reported in the literature. VS is often used as an alternative or a complement to High-throughput screening (HTS) or other methods to identify ligands for target validation or medicinal chemistry projects. This unit does not present an exhaustive review of available methods, or document specific instructions on use of individual software packages. Rather, a general overview of the methods available are presented and general strategies are described for VS based on accepted practices and the authors’ experience as computational chemists in an industrial research laboratory. First, the most common methods available for VS are reviewed, categorized as either receptor- or ligand-based. Subsequently, strategic considerations are presented for choosing a VS method, or a combination of methods, as well as the necessary steps to prepare, run, and analyze a VS campaign. © 2017 by John Wiley & Sons, Inc.</p>","PeriodicalId":38051,"journal":{"name":"Current protocols in chemical biology","volume":"9 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpch.27","citationCount":"40","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols in chemical biology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpch.27","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 40
Abstract
Virtual screening (VS) in the context of drug discovery is the use of computational methods to discover novel ligands with a desired biological activity from within a larger collection of molecules. These techniques have been in use for many years, there is a wide range of methodologies available, and many successful applications have been reported in the literature. VS is often used as an alternative or a complement to High-throughput screening (HTS) or other methods to identify ligands for target validation or medicinal chemistry projects. This unit does not present an exhaustive review of available methods, or document specific instructions on use of individual software packages. Rather, a general overview of the methods available are presented and general strategies are described for VS based on accepted practices and the authors’ experience as computational chemists in an industrial research laboratory. First, the most common methods available for VS are reviewed, categorized as either receptor- or ligand-based. Subsequently, strategic considerations are presented for choosing a VS method, or a combination of methods, as well as the necessary steps to prepare, run, and analyze a VS campaign. © 2017 by John Wiley & Sons, Inc.
虚拟小分子筛选方法与策略综述
在药物发现的背景下,虚拟筛选(VS)是使用计算方法从更大的分子集合中发现具有所需生物活性的新配体。这些技术已经使用了很多年,有广泛的方法可用,并且在文献中已经报道了许多成功的应用。VS通常被用作高通量筛选(HTS)或其他方法的替代或补充,用于靶标验证或药物化学项目中识别配体。本单元不提供对可用方法的详尽审查,也不提供关于使用单个软件包的具体说明文档。相反,提出了可用方法的总体概述,并根据公认的实践和作者在工业研究实验室作为计算化学家的经验,描述了VS的一般策略。首先,综述了目前最常用的VS检测方法,分为基于受体的和基于配体的。随后,提出了选择VS方法或方法组合的战略考虑,以及准备,运行和分析VS活动的必要步骤。©2017 by John Wiley &儿子,Inc。
本文章由计算机程序翻译,如有差异,请以英文原文为准。